Tubulin-interactive natural products as anticancer agents
- PMID: 19125622
- PMCID: PMC2765517
- DOI: 10.1021/np800568j
Tubulin-interactive natural products as anticancer agents
Erratum in
- J Nat Prod. 2011 May 27;74(5):1352
Abstract
This review provides an overview of the discovery, structures, and biological activities of anticancer natural products that act by inhibiting or promoting the assembly of tubulin to microtubules. The emphasis is on providing recent information on those compounds in clinical use or in advanced clinical trials. The vinca alkaloids, the combretastatins, NPI-2358, the halichondrin B analogue eribulin, dolastatin 10, noscapine, hemiasterlin, and rhizoxin are discussed as tubulin polymerization inhibitors, while the taxanes and the epothilones are the major classes of tubulin polymerization promoters presented, with brief treatments of discodermolide, eleutherobin, and laulimalide. The challenges and future directions of tubulin-interactive natural products-based drug discovery programs are also discussed briefly.
Similar articles
-
Natural products as antimitotic agents.Curr Top Med Chem. 2014;14(20):2272-85. doi: 10.2174/1568026614666141130095311. Curr Top Med Chem. 2014. PMID: 25434355 Review.
-
Natural products which interact with tubulin in the vinca domain: maytansine, rhizoxin, phomopsin A, dolastatins 10 and 15 and halichondrin B.Pharmacol Ther. 1992;55(1):31-51. doi: 10.1016/0163-7258(92)90028-x. Pharmacol Ther. 1992. PMID: 1287674 Review.
-
Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site.Proc Natl Acad Sci U S A. 2021 Mar 2;118(9):e2021847118. doi: 10.1073/pnas.2021847118. Proc Natl Acad Sci U S A. 2021. PMID: 33619102 Free PMC article.
-
Antimicrotubular drugs binding to vinca domain of tubulin.Mol Cell Biochem. 2003 Nov;253(1-2):41-7. doi: 10.1023/a:1026045100219. Mol Cell Biochem. 2003. PMID: 14619954 Review.
-
Mechanism of action of antitumor drugs that interact with microtubules and tubulin.Curr Med Chem Anticancer Agents. 2002 Jan;2(1):1-17. doi: 10.2174/1568011023354290. Curr Med Chem Anticancer Agents. 2002. PMID: 12678749 Review.
Cited by
-
Anti-angiogenic effects of the tubulysin precursor pretubulysin and of simplified pretubulysin derivatives.Br J Pharmacol. 2012 Nov;167(5):1048-61. doi: 10.1111/j.1476-5381.2012.02037.x. Br J Pharmacol. 2012. PMID: 22595030 Free PMC article.
-
Effect of the Marine Polyketide Plocabulin on Tumor Progression.Mar Drugs. 2022 Dec 31;21(1):38. doi: 10.3390/md21010038. Mar Drugs. 2022. PMID: 36662211 Free PMC article. Review.
-
Force Spectrum Microscopy Using Mitochondrial Fluctuations of Control and ATP-Depleted Cells.Biophys J. 2018 Jun 19;114(12):2933-2944. doi: 10.1016/j.bpj.2018.05.002. Biophys J. 2018. PMID: 29925029 Free PMC article.
-
Molecular dynamics simulation and density functional theory studies on the active pocket for the binding of paclitaxel to tubulin.J Mol Model. 2012 Jan;18(1):377-91. doi: 10.1007/s00894-011-1083-7. Epub 2011 May 3. J Mol Model. 2012. PMID: 21537957
-
Ethyl acetate extract from marine sponge Hyattella cribriformis exhibit potent anticancer activity by promoting tubulin polymerization as evidenced mitotic arrest and induction of apoptosis.Pharmacogn Mag. 2015 Apr-Jun;11(42):345-55. doi: 10.4103/0973-1296.153088. Pharmacogn Mag. 2015. PMID: 25829774 Free PMC article.
References
-
-
This manuscript is based in part on a lecture given at the American Association for Cancer Research Educational Program, Symposium on Natural Products in Anticancer Drug Discovery, San Diego, CA, April 12-16, 2008. A long abstract of the lecture has been published: Kingston DGI. American Association for Cancer Research 99th Annual Meeting Education Book. AACR; Philadelphia: 2008. Tubulin-Interactive Natural Products as Anticancer Agents; pp. 305–313.
-
-
- Newman DJ, Cragg GM. J Nat Prod. 2007;70:461–477. - PubMed
-
- Butler MS. Nat Prod Rep. 2005;22:162–195. - PubMed
-
- Clardy J, Walsh C. Nature. 2004;432:829–837. - PubMed
-
- Altmann KH, Gertsch J. Nat Prod Rep. 2007;24:327–357. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
